Q3 2012 Investor Conference Call
Tuesday, October 30, 2012
Start at approx. 2:00 p.m. CET (1:00 p.m. GMT)
Third quarter of 2012:
Bayer on track for a successful 2012
Upward trend at HealthCare and CropScience continues / Sales advanced by 11.5 percent to EUR 9,665 million / EBIT of EUR 838 million (minus 23.7 percent) / EBITDA before special items improved by 2.2 percent to EUR 1,845 million / Net income of EUR 528 million (minus 17.8 percent) / Further progress with innovation pipeline / Group forecast for 2012 confirmed more
MP3 audio recording (presentation and discussion)
| Presentation charts for conference call | Download PDF collect (403 KB) |
| Financial Report as of September 30, 2012 | Download PDF collect (2 MB) |
| Q3 2012 Analyst and Investor Briefing | Download PDF collect (338 KB) |
| Transcript | Download PDF collect (409 KB) |
| Q3 2012 All in One Package for Investors and Analysts All documents in one ZIP file | Download ZIP collect (3 MB) |